Araştırma Çıktıları

Permanent URI for this communityhttps://hdl.handle.net/11443/931

Browse

Author: search.filters.author.Bagis, SeldaHas files: No

Search Results

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    The Kinesiologic Taping Technique and its Applications
    (BAYCINAR MEDICAL PUBL-BAYCINAR TIBBI YAYINCILIK, 2011-01-01) Celiker, Reyhan; Guven, Zeynep; Aydog, Tolga; Bagis, Selda; Atalay, Ayce; Yagci, Hanife Caglar; Korkmaz, Nurten
    Kinesiotaping technique was designed by Dr.Kenzo Kase in 1970's to counteract the unwanted effects of standard taping techniques such as limitation of joint motions and functional activities. This technique facilitates circulation and motion due to elevation of skin and subcutaneous interstitial tissues, decreases inflammation and pain, increases performance, enhances neuromuscular reeducation, prevents injury and stimulates recovery. Kinesiotaping technigue has a wide range of indications. Today, in accordance with the original application techniques, different applications and indications are being innovated and research is accumulating. The aim of the present review is to summarize the current literature about kinesiotaping applications in musculoskeletal conditions and various fields such as sports rehabilitation, pediatric patients, neurologic disorders, vascular problems, lymphedema and its uses other than musculoskeletal problems. Turk J Phys Med Rehab 2011
  • No Thumbnail Available
    Item
    New Agents for the Treatment of Osteoporosis
    (BAYCINAR MEDICAL PUBL-BAYCINAR TIBBI YAYINCILIK, 2011-01-01) Guven, Zeynep; Celiker, Reyhan; Atalay, Ayce; Bagis, Selda
    Postmenopausal osteoporosis is characterized by an increase in resorption and inadequate bone formation. Alteration in bone remodeling is associated with an accelerated risk of fracture. Pharmacological agents that increase bone mass, reduce bone loss or decrease fracture risk have become available in the last few decades. Current compounds used for the treatment of osteoporosis mostly inhibit osteoclast-mediated bone resorption, while few others have an anabolic effect. Inhibition of bone resorption by currently available agents does not restore bone structure or bone that has already been lost and it is coupled with inhibition of bone formation. The identification of new pathways involved in bone turnover, will accelerate clinical research to develop new formation-stimulating and resorption-inhibiting agents with improved safety profile and efficacy in fracture prevention in osteoporosis. In the light of new data, it is estimated that novel antiosteoporotic compounds will increase considerably in the coming years. Turk J Phys Med Rehab 2011